The relative importance of peripheral vs. central chemoreceptors in causing apnea/unstable breathing during sleep is unresolved. This has never been tested in an unanesthetized preparation with intact carotid bodies. We studied three unanesthetized dogs during normal sleep in a preparation in which intact carotid body chemoreceptors could be reversibly isolated from the systemic circulation and perfused. Apneic thresholds and the CO 2 reserve (PETCO 2 eupneic -PETCO 2 apneic threshold) were determined using a pressure support ventilation (PSV) technique. Dogs were studied when both central and peripheral chemoreceptors sensed transient hypocapnia induced by the PSV and again with carotid body isolation such that only the central chemoreceptors sensed the hypocapnia. We observed that the CO 2 reserve was 4.5 Torr when the carotid chemoreceptors sensed the transient hypocapnia but more than doubled (> 9 Torr) when only the central chemoreceptors sensed hypocapnia.
INTRODUCTION
Non-REM sleep is known to unmask a highly sensitive hypocapnic-induced apneic threshold whereby very small transient reductions in arterial PCO 2 secondary to a brief ventilatory overshoot causes TE prolongation, ventilatory instability, and sometimes upper airway obstruction in selected patients (10, 11) . The relative importance of peripheral vs. central chemoreceptors in causing apnea and periodic breathing during sleep is unresolved. On the one hand, the central chemoreceptors are known to account for most of the ventilatory response to hypercapnia in the steady state (12, 28, 30, 31, 34) . On the other hand the carotid chemoreceptors respond much more quickly to step increases in PaCO 2 (7, 36 ) and the apnea that normally occurs immediately following a transient ventilatory overshoot requires the presence of the carotid chemoreceptors (5, 26) . Furthermore, in anesthetized cats, with isolated perfusion of the ponto-medullary regions, Berkenbosch et al. (3) found that breathing pattern remains stable until PaCO 2 (in the brain perfusate only) was reduced to less than 10 Torr.
These latter data suggest that the hypocapnic-induced apneic threshold of the peripheral chemoreceptors is much more sensitive than that of the central chemoreceptors. However both of these types of studies have major limitations, which preclude generalization of these findings to the intact sleeping animal or human. For example, carotid body denervation is known to markedly reduce baseline eupneic ventilation and cause CO 2 retention (13, 33) , to up-regulate aortic chemoreceptors (4, 20, 29) , to reduce the CO 2 responsiveness of central chemoreceptors (16, 25, 38) , to alter the response of central chemoreceptors to focal acidosis (18), to decrease cytochrome oxidase activity in the pre-Bötzinger complex of neonatal rats (21) , and can alter responses to systemic hypoxia and cyanide in CO 2 sensitive neurons in the retrotrapezoid nucleus (38) .
A major advantage of the Berkenbosch et al. study (3) cited above was that peripheral chemoreceptors were intact. However, their animals were also anesthetized and in order to maintain ventilatory output as brain perfusate PCO 2 was lowered, peripheral chemoreceptors had to be stimulated by maintaining systemic arterial PCO 2 > 50 Torr and PO 2 < 45 Torr. It is important, then, that the relative sensitivities of the two sets of chemoreceptors be quantified under physiologic conditions in the intact, sleeping animal. Accordingly, we tested our hypothesis that the central chemoreceptors are less sensitive than are the peripheral chemoreceptors to dynamic reductions in PaCO 2 secondary to transient ventilatory overshoots in unanesthetized, carotid sinus-perfused dogs during normal sleep. In this preparation, the carotid chemoreceptors are intact and provide tonic input to the medulla but are unable to sense imposed changes in systemic PaCO 2 .
METHODS
Studies were performed on 3 unanesthetized, young (1-2 years of age) female, mixedbreed dogs (20) (21) (22) (23) (24) (25) . Two of the dogs were also used in a different study performed concurrently with the present study. To avoid the ventilatory effects of fluctuating ovarian hormones, the dogs were always studied during anestrus which was confirmed by vaginal smear.
All studies were performed during NREM sleep. The dogs were trained to lie quietly in an airconditioned (19 -22 °C) sound-attenuated chamber. Throughout all experiments, the dogs' behavior was monitored by an investigator seated within the chamber and also by closed-circuit television. The Animal Care and Use Committee of The University of Wisconsin-Madison approved the surgical and experimental protocols for this study.
Chronic Instrumentation.
Our preparation required two surgical procedures performed under general anesthesia and with strict sterile surgical techniques and appropriate postoperative analgesics and antibiotics. In the first procedure, a chronic tracheostomy was created and a 5-lead EEG/EOG montage installed. EEG leads were tunneled subcutaneously to the cephalad portion of the dog's back where they were exteriorized.
In the second procedure, the left carotid body was denervated and the right carotid sinus was equipped with a vascular occluder and catheter to permit extracorporeal perfusion of the reversibly isolated carotid sinus/carotid body (see below). Indwelling catheters were also placed in the abdominal aorta and abdominal vena cava via branches of the femoral artery and vein respectively. Catheters were tunneled subcutaneously to the cephalad portion of the dog's back where they were exteriorized. Dogs recovered for at least 4 days prior to study.
Carotid Body Perfusion.
Dogs lay unrestrained on a bed in an air-conditioned, sound-attenuated chamber. The extracorporeal perfusion circuit was primed with ~700 mM of saline, 120 mM of allogenic blood, and 5,000 U of heparin (derived from beef lung) and supplemented with 2,500 U/hour. PCO 2 , PO 2 , and pH in the perfusion circuit were matched to a given dog's eupneic values by adjustment of the gas concentrations supplying the circuit and by addition of NaHCO 3 . The carotid sinus region was perfused at flow rates <100 mM/min, which raised the pressure in the sinus region by <10 Torr. Before data acquisition, a 30-min period of normal perfusion of the carotid sinus region was used to ensure uniformity between systemic and extracorporeal circuit blood.
Intravenous boluses of NaCN (~20 mg/kg) were used to confirm isolation of the carotid sinus during perfusion and also served to confirm denervation of the contralateral carotid body. These techniques have been described in detail in previous publications (8, 35, 37) .
Use of unilateral CBX. Our method of carotid body perfusion does require unilateral carotid body denervation on the non-perfused side. While the potential effect on the central ventilatory control system mentioned in the Introduction is a concern, we think it is probably not significant. There is evidence using this preparation in both the goat (6) and the dog (37) showing that unilateral CBX has little effect on ventilation during control, air breathing conditions or on ventilatory responses. Apparently, there is sufficient redundancy in the control system to compensate for the loss of one carotid body.
Experimental Setup and Measurements.
The dogs breathed via an endotracheal tube inserted into the chronic tracheostomy.
Airflow was measured with a heated pneumotachograph system (model 3700, Hans Rudolph, Kansas City, MO; model MP-45-14-871, Validyne, Northridge, CA) connected to the endotracheal tube. The pneumotachograph was calibrated before each study with four known flows. 1 ml arterial or perfusion circuit samples were analyzed for pH, PO 2 , and PCO 2 on a blood-gas analyzer (model ABL-505, Radiometer, Copenhagen, Denmark). The blood-gas analyzer was validated daily with dog blood tonometered with three different combinations of PO 2 and PCO 2 covering the range encountered in the experiments. Samples were corrected for both body temperature and systematic errors revealed by tonometry. Ventilation and blood pressure signals were digitized (128 Hz sampling frequency) and stored on the hard disk of a personal computer for subsequent analysis. Key signals were also recorded continuously on a polygraph (AstroMed K2G). All ventilatory data were analyzed on a breath-by-breath basis by means of custom analysis software developed in our laboratory.
Experimental Protocols
When the dogs achieved NREM sleep based on EEG criteria, the apneic threshold was determined by means of multiple trials of pressure support ventilation (see below). Any trials in which sleep state changed (arousal or REM) were excluded from analysis. These apneic threshold determinations were performed in the non-perfused state such that both central and peripheral chemoreceptors could sense the imposed hypocapnia ("central+peripheral") and, on a different day(s), after a stable carotid sinus perfusion status had been achieved with normocapnic and normoxic blood such that the carotid bodies could not sense the imposed hypocapnia ("central only"). . When the balloon was inflated and the low resistance shunt to the room sealed, the ventilator delivered preset levels of inspiratory pressure support whenever the trigger threshold was reached (i.e., the dog set its own frequency; increased pressure support resulted in increased VT). Each pressure support level was maintained for 2 minutes and then the balloon was deflated and the dog was allowed to breathe spontaneously again. At least 2 minutes elapsed before another PSV trial was performed. PSV was varied randomly over a range of 2-20 cm H 2 O. TE was measured from the end of the inspiratory flow to the onset of the next inspiration.
Use of Pressure
Under control conditions (in which the carotid chemoreceptors were not isolated, i.e., "central+peripheral") the apneic threshold was defined as the PETCO 2 obtained in the breath immediately preceding the first apneic breath. This was defined as a breath with TE prolonged to > 3 standard deviations beyond the eupneic control TE. In addition, to make our approach more conservative, we further required that this apnea was followed by at least 3 cycles of alternating hyperpnea and apnea with a consistent cycle length and that the first apnea had to occur less than 60 seconds after the initiation of PSV (i.e., hypocapnia).
Under conditions in which the carotid chemoreceptor was isolated, perfused, and with normal blood gases and pH maintained at normal sleeping eupneic levels (i.e., "central only"), periodic breathing was never observed. Thus, during carotid sinus perfusion, in order to determine the effect of hypocapnia on TE, we chose the longest TE which occurred in the twentieth to sixtieth seconds following the onset of PSV. We then associated the chosen TE with the lowest PETCO 2 observed in this interval that also preceded the longest TE. The first 20 seconds following the initiation of PSV were excluded from analysis. Thus, each trial provided one TE value and a corresponding PETCO 2 value. For each dog we then regressed the TE (i.e., longest TE -mean baseline TE) on the PETCO 2 using an exponential function model (5 -17 trials, i.e., 5-17 points, per dog). Our intent was to estimate the CO 2 reserve by determining the point at which the regression line crossed the TE value observed in the trial used for CO 2 reserve determination in the "central+peripheral" condition (but-see Results).
Interpreting the "CO 2 reserve"
We have termed the difference between the eupneic baseline PETCO 2 and the PETCO 2 at the apneic threshold the "CO 2 reserve". The CO 2 reserve so defined is an index of the propensity for instability at the prevailing eupneic ventilatory drive. It is the result of two factors, namely the gain of the ventilatory response to CO 2 below eupnea and the "plant gain" ( PaCO 2 
Statistics
Statistical comparison were made using the paired t-test with a significance level of P 0.05.
RESULTS

Carotid sinus perfusion
The effect of extra-corporeal perfusion of the carotid chemoreceptors on eupneic ventilation is shown in Tables 1 and 2 . Perfusion of the vascularly isolated carotid sinus (and therefore the carotid chemoreceptors) with normocapnic, normoxic, and normohydric blood had no systematic effect on arterial blood gases or minute ventilation, although there were some random changes in VT and f b in two of the animals. These data show a lack of a systematic effect of carotid body perfusion, per se, and are consistent with our previous findings in larger numbers of awake and sleeping dogs undergoing carotid sinus perfusion (8, 37) .
Apneic threshold and the CO 2 reserve
Figure 1A-C shows representative examples in all three dogs of the effects of several trials of PSV during non-REM sleep on the apneic threshold and the CO 2 reserve under control conditions with no exogenous carotid body perfusion (i.e., "central+peripheral"). We performed a total of 39 trials in this condition in the three dogs. In 9 of these trials the PETCO 2 was reduced less than 4.3 Torr and periodic breathing did not occur in any of these trials although isolated, prolonged TE's were noted in about half of the trials. In all "central+peripheral" trials with greater than 4.3 to 4.7 Torr decreases in PETCO 2 , produced by ~ 9 to 13 cm H 2 O pressure support ventilation, clear apnea and periodicity developed (middle panels). Apneas were longer and periodicity became more marked as hypocapnia became more severe (bottom panels). We completed a total of 29 "central+peripheral" trials in all three dogs with a decrease in PETCO 2 of more than 4.3 Torr. In 27 of these 29 trials significant TE prolongation occurred (11 of 13, 7 of 7, and 9 of 9 trials in dogs B, C, and D respectively). In 20 of the 29 trials clear periodic breathing ensued (8 of 13, 7 of 7, and 5 of 9 trials in dogs B, C, and D respectively). The latency to significant TE prolongation occurred on average at 14.2, 16.4, and 17.7 seconds following the decreases in PETCO 2 caused by pressure support ventilation for dogs B, C, and D respectively.
In contrast, as shown in figures 1A-C when the carotid bodies were isolated and perfused with normocapnic blood (i.e., "central only"), significant TE prolongation was not observed consistently in trials with decreases in PETCO 2 comparable to the periodic breathing trials in the "central+peripheral" condition (i.e. decreases in PETCO 2 secondary to pressure support ventilation >4.3 Torr). Specifically, 0 of 3, 5 of 6, and 2 of 4 trials for dogs B, C, and D respectively, showed significant TE prolongation (>control mean TE + 3SD) following the onset of pressure support ventilation. The remaining 6 trials showed no significant TE prolongation even when the PETCO 2 exceeded 4.3 Torr for 2 minutes. Furthermore, in the 7 trials in which TE was significantly prolonged the prolongations differed in three important respects from those in the "central+peripheral" trials: a) On average, the latencies were 2-fold longer in the "Central only" condition (36.8 ± 11.8 sec) and in 3 of the 7 trials latencies were greater than 45 seconds.
b) The lengths of the TE prolongations for any given reduction of PETCO 2 were less than half those observed in the "central+peripheral" condition (also see Fig. 2 The mean values for eupneic PETCO 2 and the apneic threshold PCO 2 are shown for each of the three dogs in Figure 3 . Note that the CO 2 reserve, i.e., the XPETCO 2 below eupnea required to cause apnea, ranges between 4.3 to 4.7 Torr in the three dogs studied under "central+peripheral" conditions. In contrast, when the carotid chemoreceptors were not involved in sensing transient reductions of PETCO 2 during PSV, the CO 2 reserve was increased substantially; in fact we were unable to increase pressure support ventilation and lower the PETCO 2 sufficiently to determine a clear apneic threshold without arousal even when the pressure support ventilation-induced hypocapnia was maintained for more than 90 seconds (also see Fig. 1 ).
Neuromechanical Effects on TE
During pressure support ventilation, breath timing may be influenced by both the reduction in PaCO 2 as well as by the mechanical feedback associated with an increase in VT.
The latter so-called neuromechanical effect is reflected in the first breath of PSV i.e. before the effects of hypocapnia are sensed by the peripheral chemoreceptors (see Fig. 1 ).
The first breath of pressure support ventilation tended to prolong the TE of the first breath for all dogs in the "central + peripheral" condition by 10.8±1.5% relative to control TE.
Similarly, the first breath of pressure support ventilation tended to prolong TE for all dogs in the "central only" condition by 9.9±1% relative to control TE. These "non-chemical" effects of PSV on TE were always substantially less than the 2 to 4 fold prolongation of TE observed when PETCO 2 was reduced for a few breaths and the apneic threshold was reached. These findings are consistent with the significant but relatively small effects of pressure support ventilation per se reported by Nakayama et al (27), who raised FICO 2 to prevent hypocapnia during pressure support ventilation.
DISCUSSION
The major finding of our study is that during NREM sleep in the intact, carotid sinusperfused "central only" dog, the apneic threshold is reduced and the CO 2 reserve widens, i.e., there is substantially less propensity for apnea following a transient ventilatory overshoot, when the intact but vascularly isolated carotid chemoreceptors are maintained normocapnic, normoxic, and normohydric and prevented from sensing the hypocapnia induced by pressure support ventilation. Accordingly, our findings support the conclusion that hypocapnia occurring at the carotid body chemoreceptor is required for the initiation of apnea following a ventilatory overshoot in NREM sleep within the time period normally observed in naturally occurring sleep disordered breathing. In contrast central chemoreceptors were relatively insensitive, in terms of changes in TE, to even substantial and sustained reductions in PETCO 2 accompanying hyperventilation.
Cerebral Blood Flow
The hypocapnia that accompanied pressure support ventilation may well have caused transient reductions in cerebral blood flow which in turn would have decreased the fall in brain PCO 2 relative to that in arterial PCO 2. The majority of the literature does not support a role for carotid body chemoreceptor stimulation affecting cerebral blood flow (1, 17, 19, 32) . Accordingly, we do not believe that these hypocapnia-induced decreases in cerebral blood flow would affect our conclusions because we expect this effect to be similar whether the carotid body was or was not held normocapnic.
Determining the Peripheral and Central Chemoreceptor Apneic Threshold in Intact and
Carotid Body Denervated Experimental Models
Our present findings in the intact, isolated and perfused carotid chemoreceptor model are consistent with the increase in CO 2 reserve we previously reported in the carotid body denervated animal (26) . We compare the results from these two preparations in Figure 4 . In the denervated dog, eupneic PaCO 2 was elevated significantly (+5.6 to +11.2 Torr eupneic PaCO 2 ).
However, in response to transient reductions in PETCO 2 via varying levels of PSV we also found that the CO 2 reserve was markedly widened in the carotid body denervated dogs (26) . This widening of the CO 2 reserve occurred despite a significantly elevated eupneic PaCO 2 which, by itself, would have increased plant gain and markedly reduced the CO 2 reserve and rendered the animal much more susceptible (not less susceptible as observed) to ventilatory instability and apnea (see section below on loop gain).
In the intact dog in the "central only" condition (present study) the CO 2 reserve was also markedly widened to a similar or even greater extent than in the carotid body denervated dogs.
However, in this intact model the tonic sensory input to the medullary ventilatory controller from the carotid chemoreceptors remained intact, and eupneic ventilation and PaCO 2 were not altered by normocapnic perfusion of the isolated carotid sinus. Accordingly, the entire increase in the CO 2 reserve below eupnea was due to a markedly lowered apneic threshold (also see below). We also note that neither the intact dogs in "central only" conditions nor the carotid body denervated dogs demonstrated substantially prolonged apneas or periodic breathing despite PSV-induced reductions in PETCO 2 equal to or greater than that required to reach the apneic threshold value in control conditions.
In the "central only" intact dogs of the present study, even when significant TE prolongations were noted they differed in latency and pattern relative to prolonged TE's observed in "central+peripheral" conditions. Specifically, TE prolongations in the "central only" condition were much shorter for any given reduction in PETCO 2 than in the "central+peripheral" condition and a clear stimulus:response relationship of PETCO 2 to TE was not obvious. Latencies from the onset of hypocapnia to TE prolongation were longer in the "central only", as would be expected, but were also more variable. In some instances the latencies were >45 seconds, a much longer latency than one would predict for central CO 2 chemoreception based on our previous work in the same isolated and perfused carotid sinus model in the sleeping dog (36). In these studies we used step increases in PETCO 2 to determine that ventilatory response latencies for central chemoreception averaged 30.9 ± 8.8 seconds. Accordingly, we speculate that at least some of the TE prolongations we observed in the "central only" condition may have been random events not specifically attributable to hypocapnia such as one encounters in any long run of breathing and unrelated to central chemoreception. We propose that periodic breathing requires the carotid chemoreceptors to be exposed to the transient reduction in PaCO 2 induced by the ventilatory overshoot. Finally, our findings are also consistent with the markedly depressed apneic threshold (<10 Torr PaCO 2 ) reported in the intact, anesthetized cat whose "central" PCO 2 was reduced via isolated ponto-medullary perfusion at the same time as breathing rhythm was maintained by a high systemic PaCO 2 and low PaO 2 (3) (also see Introduction).
Peripheral vs. Central Chemoreceptor Loop Gain and Apnea Susceptibility
According to control system theory, overall loop gain (G L ) determines ventilatory stability. In turn G L is determined by the product of controller gain (G C -conventionally defined by the CO 2 response slope above eupnea) and plant gain (G P ) -which is critically dependant accounts for the entire reduction in apneic threshold that we observed for the "central only"
condition.
Peripheral and Central Chemoreceptor Interactions Leading to Apnea
There are many types of interactive effects which may be required to cause cessation of respiratory rhythm, at least in the physiologic preparation. These likely include non-chemical inhibitory inputs in addition to those from chemoreceptors and may also involve communication between the peripheral and central chemoreceptors themselves.
The data from the "central+peripheral" and "central only" sleeping dog (Figure 1 ) clearly show that carotid chemoreceptor hypocapnia was required for the apnea that normally follows a transient ventilatory overshoot in NREM sleep. However, when the isolated carotid chemoreceptors were made progressively hypocapnic (or hyperoxic) in the sleeping dog, VT was reduced but apnea did not occur (35) . Accordingly we have speculated that an interactive effect between carotid body hypocapnia and lung stretch are required to cause apnea and this proposal is supported by two kinds of evidence. First Mitchell and colleagues, using an isolated in situ lung preparation in the decerebrate dog to independently manipulate blood gasses and lung stretch, have demonstrated that increased PaCO 2 reduced the slope of the relationship between TE and airway pressure i.e., lower PaCO 2 promoted longer TE at any given airway pressure or lung stretch (22) (23) (24) . Second, an interaction between carotid chemoreceptor afferents and pulmonary stretch receptor afferents has also been demonstrated to influence neuronal activity in the dorsal respiratory group and ventral respiratory group neurons of anesthetized dogs (2).
Our present findings distinguish central from peripheral chemoreceptor CO 2 sensitivity
by showing that cerebral hypocapnia and, presumably, the central chemoreceptors by themselves are not significant contributors to the apnea attending a ventilatory overshoot. We propose two potential explanations for this apparent insensitivity. One possibility, as reported by Fukuda et al. (14) , is that neural discharge from CO 2 sensitive medullary neurons on the ventral surface persisted even when the pH in the medium perfusing the brain slice was raised > 7.6. This finding is controversial however, as Guyenet et al. A quick response to increases or decreases in PaCO 2 (36); c) A high response gain to reductions in PaCO 2 below eupnea that are achieved during transient hyperventilation (Fig. 5) .
Accordingly, carotid bodies were shown to be required to initiate apnea in the time interval encountered in naturally occurring sleep apnea following a ventilatory overshoot and decreased PaCO 2 (26) .
These same characteristics might also indicate a role for the carotid body chemoreceptors in the cycling of ventilatory overshoots and undershoots observed in many forms of periodic breathing such as those that occur during sleep in congestive heart failure, in hypoxia, and in central, obstructive, or mixed sleep apnea. For example, they probably play a role in the ventilatory overshoot that inevitably follows apnea/hypopnea not only because of their rapid response and high gain but because they are also the site of hypoxic/hypercapnic interaction (9) and therefore would provide a substantial ventilatory overshoot in response to asphyxic stimuli present during periods of apnea or hypoventilation.
Our findings should not be construed to mean that there is no role for the central 
